First Trust Direct Indexing’s Nu Skin NUS Stock Holding History

First Trust Direct Indexing’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,270	Closed	-$140K	–	1000
2024 Q2	$140K	Buy	+13,270	New	+$168K	0.01%	866
2021 Q1	–	Sell	-2,984	Closed	-$163K	–	782
2020 Q4	$163K	Buy	+2,984	New	+$157K	0.04%	390

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Trust Direct Indexing's NUS Position: Q3 2024 in Review

First Trust Direct Indexing sold out of Nu Skin (NUS) in Q3 2024, closing a stake of 13,270 shares — an estimated $140K sold.

First Trust Direct Indexing first reported a position in NUS in Q4 2020 and held it in 2 quarters. The position peaked at $163K in Q4 2020. 203 funds tracked by Wall St. Rank hold NUS as of Q3 2024.

First Trust Direct Indexing reported no remaining Nu Skin position as of Q3 2024 after selling out during the quarter.
First Trust Direct Indexing sold 13,270 Nu Skin shares in Q3 2024, an estimated $140K.
First Trust Direct Indexing first reported a position in Nu Skin in Q4 2020 and held it in 2 quarters.
First Trust Direct Indexing's Nu Skin position peaked at $163K in Q4 2020.
203 funds tracked by Wall St. Rank held Nu Skin as of Q3 2024.

Based on First Trust Direct Indexing's 13F filing for Q3 2024, filed 25 Oct 2024.